Search Results 251-260 of 16273 for monoclonal antibody

1. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

2. Mayo Clinic clinical trials in patients with tumor-induced osteomalacia

   An FGF23 monoclonal antibody (burosumab) was recently approved by the U.S. Food and Drug Administration for use in patients in whom surgical tumor resection ...

3. Clinical trials - Oncology (Medical)

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

4. Expertise in defining and treating neuromyelitis optica spectrum disease - Mayo Clinic

   Three monoclonal antibody therapies — eculizumab, inebilizumab and satralizumab — have been approved for adults with NMOSD and AQP4-IgG autoantibodies.

5. Untitled

   In other words, being infected and receiving monoclonal antibodies prevents you from developing a protective immune response. In a sense, we are artificially ...

6. Three new high-tech tools for state scientists from Minnesota Partnership - Mayo Clinic News Network

   Researchers: Jeffrey Salisbury, Ph.D., Mayo Clinic; Claudia Neuhauser, Ph.D., University of Minnesota. Antibody phage display for monoclonal antibodies.

7. Clinical trials - Oncology (Medical)

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal ... monoclonal antibody, and compare them with ...

8. Plasma Cell Disorders Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability ... monoclonal antibody (mAb). Renal impairment is a major complication of ...

9. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

10. Pseudomembranous colitis - Diagnosis & treatment - Mayo Clinic

    The U.S. Food and Drug Administration (FDA) has approved the use of the human monoclonal antibody bezlotoxumab to reduce the risk of recurrence of C.